Hjem › Beta-talassemi › New York
Kliniske studier for Beta-talassemi i New York
5 studier for Beta-talassemi søker deltakere på steder i New York.
Offisiell studietekst (engelsk)
Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia
- New York Presbyterian Hospital, New York
RekruttererFase 2
Alder 6 til 17 · Alle kjønn · Oppdatert 10. jul. 2026 · NCT04143724A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)
- Memorial Sloan Kettering Suffolk - Commack (Consent only), Commack
- Memorial Sloan Kettering Westchester (Consent only), Harrison
- Memorial Sloan Kettering Nassau (All protocol activities), Rockville Centre
RekruttererFase 2
Alder 2 til 50 · Alle kjønn · Oppdatert 3. jun. 2026 · NCT05736419Evaluation of Efficacy and Safety of a Single Dose of CTX001 in Participants With Transfusion-Dependent β-Thalassemia and Severe Sickle Cell Disease
- New York Presbyterian Hospital - Morgan Stanley Children's Hospital, New York
RekruttererFase 3
Alder 12 til 35 · Alle kjønn · Oppdatert 23. mar. 2026 · NCT05477563AlloSCT for Malignant and Non-malignant Hematologic Diseases Utilizing Alpha/Beta T Cell and CD19+ B Cell Depletion
- New York Medical College, Valhalla
RekruttererFase 2
1 Day – 30 Years · Alle kjønn · Oppdatert 8. aug. 2025 · NCT04099966A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
- Cohen Children's Medical Center, New Hyde Park
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 11. feb. 2025 · NCT06271512Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.